Matthew Dean Price

Matthew Dean Price

Auto-generated profile, based on publicly available information

Matthew Dean Price

Johns Hopkins University Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in JCO Global Oncology
Verified
Journal Article
Open access
MPMatthew D. Price
Matthew D. Price
ARAnne F. Rositch
Anne F. Rositch
FDFlorence PARENT Dedey
Florence PARENT Dedey
MMMeghan E. Mali
Meghan E. Mali
KBKirstyn E. Brownson
Kirstyn E. Brownson
ESEdward Kofi Sutherland
Edward Kofi Sutherland
PURPOSE: Breast cancer is the most frequent cancer and second most common cause of cancer-related death in Ghana. Early detection and access to diagnostic services are vital for early treatment initiation and improved survival. This study characterizes the geographic access to hospital-based breast cancer diagnostic services in Ghana as a framework for expansion. METHODS: A cross-sectional hospital-based survey was completed in Ghana from November 2020 to October 2021. Early diagnostic services, as defined by the National Comprehensive Cancer Network (NCCN) Framework for Resource Stratification, was assessed at each hospital. Services were characterized as available >80% of the time in the previous year, 80% of the time, with 43% of the population living within 45 km. Ten of the 12 met full NCCN Core criteria, and none met full NCCN Enhanced criteria. An additional 12 hospitals were identified that provide the majority of NCCN Basic services but lack select services necessary to meet this criterion. Expansion of services in these hospitals could result in an additional 20% of the population having access to NCCN Basic-level early diagnostic services within 45 km. CONCLUSION: Hospital-based services for breast cancer early diagnosis in Ghana are available but sparse. Many hospitals offer fragmented aspects of care, but only a limited number of hospitals offer the full NCCN Basic or Core level of care. Understanding current availability and geographical distribution of services provides a framework for potential targeted expansion of services.

14 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMatthew D. Price
Matthew D. Price
MMMeghan E. Mali
Meghan E. Mali
AEAdjei Ernest
Adjei Ernest
AAAfua O. D. Abrahams
Afua O. D. Abrahams
EGEric Goold
Eric Goold
ESEdward K. Sutherland
Edward K. Sutherland
Introduction: Breast cancer poses a significant health challenge in Sub-Saharan Africa, particularly in Ghana, where late-stage diagnoses and limited healthcare access contribute to elevated mortality rates. This study focuses on the crucial role of pathology and laboratory medical (PALM) services in the timely diagnosis of breast cancer within Ghana. Methods: A cross-sectional survey of hospitals was completed from November 2020 to October 2021, with 94.8% of identified in-country hospitals participating. Pathology service-related parameters assessed included whether pathology was available for the diagnosis of breast cancer on-site or via external referral, the number of pathology personnel, additional breast cancer diagnostic capabilities including estrogen and progesterone and/or HER2 testing, and the time from biopsy to patients receiving their results. Geospatial mapping was used to identify areas of limited access. Results: Of the 328 participating hospitals, 136 (41%) reported breast cancer pathology services, with only 6 having on-site capabilities. Pathology personnel, comprising 15 consultants and 15 specialists, were concentrated in major referral centers, particularly in Greater Accra and Kumasi. An assessment of referral patterns suggested that 75% of the population reside within an hour of breast cancer pathology services. Among the 136 hospitals with access to breast cancer pathology, only a limited number reported that results included ER/PR (38%) and HER2 testing (33%). Conclusion: Ghana has been able to ensure significant pathology service availability through robust referral pathways with centralized labs. Despite this, difficulties persist with the majority of pathology results not including hormone receptor testing which is important in providing tumor specific treatment.

19 October 2024 in Journal of Surgical Research
Verified
Journal Article
Closed access
MPMatthew D. Price
Matthew D. Price
KMKatherine M. McDermott
Katherine M. McDermott
RGRahul Gorijavolu
Rahul Gorijavolu
CCCharbel Chidiac
Charbel Chidiac
YLYao Li
Yao Li
INIsam W. Nasr
Isam W. Nasr

10 May 2017 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MPMatthew D. Price
Matthew D. Price
HSHaadi T. Shalabi
Haadi T. Shalabi
BGBlasco Guzhñay
Blasco Guzhñay
SSSaggah T. Shalabi
Saggah T. Shalabi
RPRaymond R. Price
Raymond R. Price
EREdgar B. Rodas
Edgar B. Rodas

1 August 2024 in JCO Global Oncology
Verified
Journal Article
Closed access
MPMatthew D. Price
Matthew D. Price
MMMeghan E. Mali
Meghan E. Mali
FDFlorence PARENT Dedey
Florence PARENT Dedey
KDKlenam Dzefi-Tettey
Klenam Dzefi-Tettey
YLYao Li
Yao Li
ESEdward Kofi Sutherland
Edward Kofi Sutherland
PURPOSE: Breast cancer is the leading type of cancer diagnosed and the second leading cause of cancer-related death in Ghana. Mammography and ultrasound have proven benefits in the early detection of breast cancer. This study evaluates mammography, breast ultrasound, and radiology work force availability throughout Ghana. METHODS: A survey was administered to all hospitals in Ghana from November 2020 to October 2021. Mammography, breast ultrasound services, and the number of radiologists were assessed. For mammography, the number performed per month, cost incurred by the patient, where images were read, and how long it took to receive reports were also assessed. Health Facilities Regulatory Authority records on diagnostic centers were obtained to identify additional in-country breast imaging services. RESULTS: Three hundred and twenty-eight of 346 hospitals participated in the survey (95%). Only 21 hospitals reported on-site mammography. One hospital reported performing >100 mammographies per month. The average cost to the patient ranged from 100 to 500 Cedis ($17-87 US dollars [USD]), although three hospitals performed mammography at no cost. An additional 10 mammography machines were identified at diagnostic centers throughout the country, with 41.3% of the female population living within 1 hour of mammography services. There were 135 hospital-based breast ultrasound services identified with 69.5% of the female population living within 1 hour of these services. There were an additional 190 ultrasound machines at diagnostic centers. There were 96 in-country radiologists identified. CONCLUSION: Although there is limited availability and utilization of mammography in Ghana, there is more readily available ultrasonography. A focus on increasing breast cancer early diagnostic capabilities with breast ultrasound should be prioritized in addition to further expansion of the radiology workforce.

6 December 2024 in Pediatric Transplantation
Verified
Journal Article
Closed access
MPMatthew D. Price
Matthew D. Price
JRJessica Moore Ruck
Jessica Moore Ruck
NDNatasha Dilwali
Natasha Dilwali
ATAnanda Thomas
Ananda Thomas
AZAlice Zhou
Alice Zhou
STSociety Of Pediatric Liver Transplantation
Society Of Pediatric Liver Transplantation